P
US11071706B2ActiveUtilityPatentIndex 54

Cosmetic composition containing, as active ingredient, albumin, hyaluronic acid or collagen in cell culture medium

Assignee: BIOCOZ GLOBAL KOREA CORPPriority: Apr 1, 2016Filed: Mar 31, 2017Granted: Jul 27, 2021
Est. expiryApr 1, 2036(~9.7 yrs left)· nominal 20-yr term from priority
Inventors:KIM CHAN WHAKIM YOUNG JOON
A61P 17/02A61K 33/14A61K 33/06A61K 31/728A61K 31/51A61K 31/455A61K 31/4415A61K 31/047A61K 31/198A61K 8/735A61K 8/44C12N 5/0625A61K 35/36A61K 35/33A61K 8/981A61K 8/64A61P 17/00C12N 2533/80C12N 2533/54C12N 2533/50C12N 2500/38C12N 2500/32C12N 2500/30C12N 2500/14C12N 2500/12A61Q 19/08A61Q 19/00A61P 37/08A61P 17/10A61P 17/06A61P 17/04A61K 38/39A61K 38/385A61K 8/65A61K 38/38A61Q 19/005A61K 47/02A61K 8/675A61K 47/12A61K 47/22A61K 8/19A61K 8/673A61K 8/36A61K 47/26A61P 27/02
54
PatentIndex Score
0
Cited by
18
References
6
Claims

Abstract

The present invention relates to a cosmetic or pharmaceutical composition containing a cell culture medium and, as an active ingredient, albumin, hyaluronic acid or collagen. The composition according to the present invention can be useful as a cosmetic or pharmaceutical composition for alleviating, preventing or treating skin wounds, skin diseases or skin conditions, by increasing the recovery capability of cells.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method for improving skin condition of a subject, comprising administering a cosmetic composition to the subject,
 said composition comprising 
 a cell culture medium; and 
 one or more selected from the group consisting of albumin, hyaluronic acid, and collagen; 
 wherein the cell culture medium comprises an amino acid component, a vitamin component, and an inorganic salt component, and 
 wherein the amino acid component comprises 1 part by weight of serine, 0.2 to 1.2 parts by weight of glycine, 0.08 to 0.3 part by weight of L-alanine, 2 to 7 parts by weight of L-arginine hydrochloride, 0.2 to 0.9 part by weight of L-cysteine hydrochloride-monohydrate, 10 to 18 parts by weight of L-glutamine, 0.8 to 2.0 parts by weight of L-histidine hydrochloride-monohydrate, 1.0 to 5.0 parts by weight of L-lysine hydrochloride, 0.2 to 1.2 parts by weight of L-methionine, 0.2 to 1.2 parts by weight of L-proline, 1.0 to 5.0 parts by weight of L-threonine, and 1.0 to 5.0 parts by weight of L-valine, based on the 1 part by weight of serine. 
 
     
     
       2. The method of  claim 1 , comprising applying the cosmetic composition to a target skin of the subject. 
     
     
       3. The method of  claim 2 , wherein the subject is a mammal. 
     
     
       4. A method for preventing or treating a skin disorder in a subject in need thereof, comprising administering a pharmaceutical composition to the subject,
 said composition comprising 
 a cell culture medium; and 
 one or more selected from the group consisting of albumin, hyaluronic acid, and collagen; 
 wherein the cell culture medium comprises an amino acid component, a vitamin component, and an inorganic salt component, and 
 wherein the amino acid component comprises 1 part by weight of serine, 0.2 to 1.2 parts by weight of glycine, 0.08 to 0.3 part by weight of L-alanine, 2 to 7 parts by weight of L-arginine hydrochloride, 0.2 to 0.9 part by weight of L-cysteine hydrochloride-monohydrate, 10 to 18 parts by weight of L-glutamine, 0.8 to 2.0 parts by weight of L-histidine hydrochloride-monohydrate, 1.0 to 5.0 parts by weight of L-lysine hydrochloride, 0.2 to 1.2 parts by weight of L-methionine, 0.2 to 1.2 parts by weight of L-proline, 1.0 to 5.0 parts by weight of L-threonine, and 1.0 to 5.0 parts by weight of L-valine, based on the 1 part by weight of serine. 
 
     
     
       5. The method of  claim 4 , comprising applying the pharmaceutical composition to a target skin of the subject. 
     
     
       6. The method of  claim 5 , wherein the subject is a mammal.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.